(a) A therapy management contract shall apply only to conditions for which protocols have been agreed to by an authorized prescriber and a licensed pharmacist in accordance with the regulations adopted under this subtitle.
(b) A therapy management contract shall include:
(1) A statement that none of the parties involved in the therapy management contract have been coerced, given economic incentives, excluding normal reimbursement for services rendered, or involuntarily required to participate;
(2) Notice to the patient indicating:
(i) That the patient may terminate the therapy management contract at any time; and
(ii) The procedure by which the patient may terminate the therapy management contract;
(3) A procedure for periodic review by the authorized prescriber, of the drugs modified pursuant to the agreement or changed with the consent of the authorized prescriber; and
(4) Reference to a protocol, which will be provided to the patient on request.
(c) Any party to the therapy management contract may terminate the contract at any time.
(d) The Board may assess a fee, as established in regulation, for approval of a pharmacist to enter into a prescriber–pharmacist agreement.